Dr. Gita Suneja is associate professor in the departments of radiation oncology and global health at Duke University. Her clinical specialties include the treatment of breast and gynecologic malignancies. Her research program is focused on health services research, access to cancer care and patient outcomes. She has a particular interest in disparities in cancer treatment and outcomes of HIV-infected cancer patients, both in the United States and Botswana.
Dr. Suneja graduated from the Warren Alpert Medical School of Brown University and completed her residency training in radiation oncology at the University of Pennsylvania, where she served as chief resident. Dr. Suneja then pursued a master's degree in health policy research from the University of Pennsylvania, where she was a fellow in the Leonard Davis Institute for Health Economics. She has worked collaboratively with investigators at the National Cancer Institute and American Cancer Society. Her research findings have been published in journals such as Journal of Clinical Oncology and The Lancet Oncology. Her work has also received national media attention from Newsweek Magazine and National Public Radio.
At Duke, Dr. Suneja will be working to address disparities in cancer treatment in HIV-infected people and developing programs to grow cancer capacity in low and middle income countries.
Efstathiou JA, Heunis M, Karumekayi T, Makufa R, Bvochora-Nsingo M, Gierga DP, Suneja G, Grover S, Kasese J, Mmalane M, Moffat H, von Paleske A, Makhema J, Dryden-Peterson S (2016). Establishing and Delivering Quality Radiation Therapy in Resource-Constrained Settings: The Story of Botswana. J Clin Oncol, 34(1), 27-35.
Coghill AE, Shiels MS, Suneja G, Engels EA (2016). Reply to L. Dal Maso et al. J Clin Oncol, 34(4), 390-1.
Shiels MS, Pfeiffer RM, Besson C, Clarke CA, Morton LM, Nogueira L, Pawlish K, Yanik EL, Suneja G, Engels EA (2016). Trends in primary central nervous system lymphoma incidence and survival in the U.S.LID - 10.1111/bjh.14073 [doi]. (Epub ahead of print) Br J Haematol.
Orton A, Boothe D, Williams N, Buchmiller T, Huang YJ, Suneja G, Poppe M, Gaffney D (2016). Brachytherapy improves survival in primary vaginal cancer.LID - S0090-8258(16)30068-3 [pii]LID - 10.1016/j.ygyno.2016.03.011 [doi]. (Epub ahead of print) Gynecol Oncol.
Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, Werner TL, Gaffney DK (2016). Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival.LID - S0090-8258(16)30078-6 [pii]LID - 10.1016/j.ygyno.2016.03.021 [doi]. (Epub ahead of print) Gynecol Oncol.
Suneja G, Brown D, Chang A, Erickson B, Fidarova E, Grover S, Mahantshetty U, Nag S, Narayan K, Bvochora-Nsingo M, Viegas C, Viswanathan AN, Lin MY, Gaffney D. American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. Brachytherapy. 2016 Dec 2. pii: S1538-4721(16)30572-4. doi:10.1016/j.brachy.2016.10.007. [Epub ahead of print] PubMed PMID: 27919654
Suneja G, Coghill A. Cancer care disparities in people with HIV in the United States. Curr Opin HIV AIDS. 2017 Jan;12(1):63-68. PubMed PMID: 27753654.
Boothe D, Orton A, Odei B, Stoddard G, Suneja G, Poppe MM, L Werner T, Gaffney DK. Corrigendum to "Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival" [Gynecol. Oncol. 141 (2016) 421-427]. Gynecol Oncol. 2016 Dec;143(3):690-691.doi: 10.1016/j.ygyno.2016.09.023. PubMed PMID: 27726921
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG). Anker CJ, Grossmann KF, Atkins MB, Suneja G, Tarhini AA, Kirkwood JM. Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):632-46. doi: 10.1016/j.ijrobp. 2016.01.038. Review. PMID: 27131079
Disparities in cancer treatment among patients infected with the human immunodeficiency virus. Suneja G, Lin CC, Simard EP, Han X, Engels EA, Jemal A. Cancer. 2016 Aug 1;122(15): 2399-407. doi: 10.1002/cncr.30052. Epub 2016 May 17. PMID: 27187086
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma. Ray A, Williams MA, Meek SM, Bowen RC, Grossmann KF, Andtbacka RH, Bowles TL, Hyngstrom JR, Leachman SA, Grossman D, Bowen GM, Holmen SL, VanBrocklin MW, Suneja G, Khong HT. Oncotarget. 2016 Jul 6. doi: 10.18632/oncotarget.10453. PMID: 27391442
HIV Infection and Survival Among Women With Cervical Cancer. Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, Grover S, Chiyapo S, Ramogola-Masire D, Kebabonye-Pusoentsi M, Clayman R, Mapes AC, Tapela N, Asmelash A, Medhin H, Viswanathan AN, Russell AH, Lin LL, Kayembe MK, Mmalane M, Randall TC, Chabner B, Lockman S. J Clin Oncol. 2016 Aug 29. pii: JCO679613. PMID: 27573661
Adjuvant radiotherapy for atypical meningiomas. Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT, Shrieve DC.J Neurosurg. 2016 Sep 9:1-7. PMID: 27611201